MDPI is committed to supporting the academic community, nurturing talent and advancing science. Awards are an important part of the research landscape and play a vital role in helping academics gain recognition, especially young researchers as they embark on new research avenues.

In 2022, our journals presented a total number of 394 Awards, including Travel Awards, Young Investigator Awards, Best PhD Thesis Awards, Best Paper Awards, and Outstanding Reviewer Awards, with several winners announced for some of the awards. The total prize sum amounted to just under 580,000 Swiss francs (CHF), or approximately 650,000 US dollars. Overall, more than 720 scholars were awarded.

The majority of the awards were dedicated to young researchers in relatively early stages of their careers. This encompassed 66 of the afore-mentioned Travel Awards, 60 Young Investigator Awards, supporting research projects and conference attendance, as well as 51 Best PhD Thesis Awards. Additionally, 113 Best Paper Awards were given by our journals. The selection committees were entrusted with identifying the most impactful and novel research and review articles published in their journal within a given year.

MDPI will continue its support and recognition for the academic community moving forward, sponsoring new awards across disciplines. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:

To explore more MDPI awards, please click here.

MDPI will attend the American Congress of Rehabilitation Medicine (ACRM) 100th Annual Conference. The 2023 annual meeting of ACRM is the world’s largest interdisciplinary rehabilitation research event. Rehabilitation professionals and community members from around the globe are encouraged to join. With 150+ inter-professional groups at ACRM, including community groups, committees, and task forces, the 100th anniversary conference is planning 4 powerful plenaries, 15+ symposia, 300+ educational sessions, symposia and lectures, and 600+ scientific papers and digital poster presentations, etc.

To enhance patient care, the presentation of science by researchers is required, and to inform and improve research, feedback from the clinicians is required. The aim of the ACRM 100th annual conference is to encourage attendees to join the discussions and collaborations in order to help move the field of physical medicine and rehabilitation forward.

The following MDPI journals will be represented:

• Healthcare;
• JCM;
• Diagnostics;
• JPM;
• Trauma Care;
• Nutrients;
• Hygiene;
• IJERPH;
• Children;
• Societies.

If you plan on attending this conference, please feel free to stop by our booth #413 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://conference.acrm.org/.

MDPI will attend the 14th Asian Congress of Nutrition (ACN). The conference theme will be “Feeding the Future by Sustainable Nutrition”. Since 1973, the ACN has been held by the Federation of Asian Nutrition Societies (FANS) every four years. The conference committee categorized eight sessions in order to cover the board topics, namely: 1. Nutrition and Sustainable Development; 2. Basic Nutrition and Research; 3. Public Nutrition and Health; 4. Food and Nutrition; 5. Nutrition Across a Lifespan; 6. Nutrition Education; 7. Clinical Nutrition; and 8. Precision Nutrition.

The aim of the conference is to encourage discussion and gain valuable knowledge on a broad range of nutritional issues, such as food and energy storage, the coexisting malnutrition situation, the emerging prevalence of nutrition-related chronic diseases, the aging of societies, etc.

The following MDPI journals will be represented:

• Nutrients;
• Healthcare;
• Metabolites;
• Obesities;
• Nutraceuticals;
• CIMB.

If you plan on attending this conference, please feel free to stop by our booth (#D01) and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://acn2023.sciconf.cn/en/web/index/11826.

MDPI will attend the American Academy of Pediatrics 2023 National Conference & Exhibition. This event will be held in Washington D.C. for five days from Friday, 20 October, to Tuesday, 24 October 2023.

The following MDPI journals will be represented:

• Children;
• JCM;
• Medicina;
• Healthcare;
• IJERPH;
• JPM;
• Clinpract;
• Diagnostics;
• Medicines.

If you plan on attending this conference, please stop by our booth and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://aapexperience.org/.

MDPI’s Young Investigator Awards recognize promising young researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2022 in medicine and pharmacology. The winners were selected by the journals’ Award Evaluation Committee.

We would like to warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Biomedicines:

• Yuyan Jiang, Stanford University, USA
• Billy Wai-Lung Ng, Chinese University of Hong Kong, China

Cancers:

• Ashleigh Poh, The Olivia Newton-John Cancer Research Institute, Australia
• Miranda Fidler-Benaoudia, University of Calgary, Canada

Current Oncology:

• Bishal Gyawali, Queen’s University, Canada

Healthcare:

• Shahnawaz Anwer, Hong Kong Polytechnic University, Hong Kong

JCM:

• Jan Bednarsch, Universitätsmedizin Berlin, Germany

JPM:

• Anda Mihaela Naciu, Fondazione Policlinico Universitario Campus Bio-Medico, Italy
• Jerome Lechien, University of Mons, Belgium

Pharmaceuticals:

• Daniele Bertoglio, University of Antwerp, Belgium

Pharmaceutics:

• Gregor Fuhrmann, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany

TropicalMed:

• Haley Adcox, Virginia Commonwealth University, USA

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and a form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to the advancement of their fields.

For more MDPI awards, please click here.

We are proud to recognize the winners of MDPI’s 2022 Travel Awards in medicine and pharmacology category for their outstanding presentations.

MDPI journals regularly offer Travel Awards to encourage talented junior scientists to present their research at academic conferences in specific fields, which helps to enhance their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to congratulate the winners of the 2022 Travel Awards and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Antibiotics:

• Filip Jansåker, Lund University, Lund, Sweden
• Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal

Cancers:

• Diego de Miguel Perez, Icahn School of Medicine at Mount Sinai, USA
• Luigi Russo, Italian Institute of Technology (IIT), Italy

Current Oncology:

• Sneha Sethi, University of Adelaide, Australia
• Xiyin Wang, Indiana University School of Medicine, USA

Dentistry Journal:

• Sonia Nath, University of Adelaide, Australia
• Konstantina Kritikou, Carol Davila University of Medicine and Pharmacy, Romania

Diagnostics:

• Adrien Holzgreve, The University Hospital of Munich, Germany

Hemato:

• Antonella Padella, Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l., Italy

JCDD:

• Susanna Cooper, St. George’s University of London, UK
• Renée Tillie, Maastricht University Medical Center, the Netherlands

JCM:

• Max Lennart Eckstein, University of Bayreuth, Germany
• Lorenzo Bertani, University of Pisa, Italy

Pharmaceutics:

• Yuxue Cao, University of Queensland, Australia
• Flávia Sousa, Italian Institute of Technology, Italy

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form ot recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize the winners for the year 2022 in medicine and pharmacology for their outstanding contributions among the extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievements. MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

• Maxime Pichon, Centre Hospitalier Universitaire de Poitiers, France
• Violeta Popovici, Ovidius University of Constanta, Romania
• Yosra A. Helmy, University of Kentucky, USA

Cancers:

• Antonio G. Solimando, Aldo Moro University of Bari, Italy
• Linlin Guo, The Ohio State University Medical Center, USA
• Ravindra Deshpande, Wake Forest School of Medicine, USA
• Songli Zhu, Fred Hutchinson Cancer Research Center, USA
• Antonella Argentiero, IRCCS Istituto Tumori “Giovanni Paolo II” of Bari, Italy
• Camelia Coada, Alma Mater Studiorum-University of Bologna, Italy
• Chenghui Li, University of Arkansas for Medical Sciences, USA
• Laurentiu Pop, University of Texas Southwestern Medical Center, USA
• Muhammad Fazal Ijaz, Dongguk University, Republic of Korea
• Rafał Watrowski, University of Freiburg, Germany
• Ruben C. Petreaca, The Ohio State University, USA
• Ruchi Roy, Rush University Medical Center, USA
• Salvatore Cocuzza, University of Catania, Italy
• Santosh Kumar Singh, Morehouse School of Medicine, USA
• Sergei Boichuk, Kazan State Medical University, Russia
• Simon John Christoph Soerensen, Stanford University, USA
• Takuya Koie, Gifu University, Japan
• Teresa Rubio-Tomás, Foundation for Research and Technology Hellas, Greece
• Teruki Nii, Kyushu University, Japan
• Tomasz Marjanski, Medical University of Gdansk, Poland

Current Oncology:

• Kristen Haase, The University of British Columbia, Canada
• Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
• Makoto Endo, Kyushu University, Japan

Healthcare:

• Tefera Tadesse, Addis Ababa University, Ethiopia
• Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
• Ryuichi Ohta, Unnan City Hospital, Japan

JCM:

• Henry Sutanto, Cardiovascular Research Institute Maastricht, the Netherlands
• José-María Sánchez-González, University of Seville, Spain
• Emmanouil Kapetanakis, General Hospital of Piraeus “Tzaneio”, Greece

JPM:

• Eleonora Topino, Libera Università Maria Santissima Assunta (LUMSA), Italy
• Rodolfo Reda, Sapienza University of Rome, Italy
• Giulio Francesco Romiti, Sapienza University of Rome, Italy
• Maria Gabriella Melchiorre, IRCCS INRCA—National Institute of Health and Science on Ageing, Italy
• James Walter, ¹Hines VA Hospital, USA; ² Loyola Medical Center, USA

Medical Sciences:

• Vasiliki Tsigkou, Sotiria Hospital, Greece

Pharmaceutics:

• Flavia Zacconi, Pontificia Universidad Católica de Chile, Chile
• Bhupendra Prajapati, Ganpat University, India
• Van-An Duong, Gachon University, Republic of Korea
• Ashish Agrawal, Indian Institute of Technology (BHU), India

Tomography:

• Aydin Eresen, University of California Irvine, USA

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

MDPI’s Best PhD Thesis Awards aim to recognize young scholars who are deemed to have produced the most outstanding PhD thesis in their fields of research and to encourage them to continue their outstanding work and further contributions to their field.

We would like to congratulate the winners of the 2022 Best PhD Thesis Awards in medicine and pharmacology and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Cancers:

• “Uncovering Novel Prognostic and Predictive Epigenetic Biomarkers in Malignant Testicular Germ Cell Tumors”

by João Pedro da Silva Machado Lobo, University of Porto, Portugal

• “Metastatic Recurrence in Colorectal Cancer Arises from Residual EMP1+ Cells”

by Adrià Cañellas Socias, University of Barcelona, Spain

Healthcare:

• “Investigating Novel Aspects of the Blood–Brain Barrier Using High-Resolution Electron Microscopy”

by Shireen Mentor, University of Cape Town, South Africa

JPM:

• “An Epidemiological Approach to Study The Interplay between Genome, Epigenome and Exposome in Women”

by Roberta Magnano San Lio, University of Catania, Italy

Pharmaceutics:

• “Intravitreal Liposomes as Ocular Drug Delivery Systems: Vitreal Interactions, Retinal Permeation and Drug Release Characteristics”

by Shirin Tavakoli, University of Helsinki, Finland

TropicalMed:

• “Microbiome-Mediated Colonization Resistance: Defense against Enteropathogens and Multi-Drug Resistant Organisms”

by Quinten Ducarmon, Leiden University Medical Center, the Netherlands

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

For more MDPI awards, please click here.

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected review and research papers through a rigorous evaluative process based on criteria such as the scientific merit, overall impact, and quality of presentation of the papers published in the journal.

We are honored to present the winners for the year 2022 in medicine and pharmacology, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications. MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

• “Development and Challenges of Antimicrobial Peptides for Therapeutic Applications”
  by Charles H. Chen and Timothy K. Lu
  Antibiotics 2020, 9(1), 24; https://doi.org/10.3390/antibiotics9010024

• “Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries”
  by Philip Joosten, Daniela Ceccarelli, Evelien Odent, Steven Sarrazin, Haitske Graveland, Liese Van Gompel, Antonio Battisti, Andrea Caprioli, Alessia Franco, Jaap A. Wagenaar et al.
  Antibiotics 2020, 9(2), 87; https://doi.org/10.3390/antibiotics9020087

Dentistry Journal:

• “Management of Peri-Implantitis Lesions without the Use of Systemic Antibiotics: A Systematic Review”
  by Ahsen Khan, Ankit Goyal, Scott D. Currell and Dileep Sharma
  Dent. J. 2020, 8(3), 106; https://doi.org/10.3390/dj8030106

• “Associations among Primary Stability, Histomorphometric Findings, and Bone Density: A Prospective Randomized Study after Alveolar Ridge Preservation with a Collagen Cone”
  by Sigmar Schnutenhaus, Werner Götz, Jens Dreyhaupt, Heike Rudolph, Ralph G. Luthardt and Cornelia Edelmann
  Dent. J. 2020, 8(4), 112; https://doi.org/10.3390/dj8040112

Healthcare:

• “Novel Prefrontal Synthesis Intervention Improves Language in Children with Autism”
  by Andrey Vyshedskiy, Edward Khokhlovich, Rita Dunn, Alexander Faisman, Jonah Elgart, Lisa Lokshina, Yuriy Gankin, Simone Ostrovsky, Lauren deTorres, Stephen M. Edelson et al.
  Healthcare 2020, 8(4), 566; https://doi.org/10.3390/healthcare8040566

• “The Effects of Long-Term 40-Hz Physioacoustic Vibrations on Motor Impairments in Parkinson’s Disease: A Double-Blinded Randomized Control Trial”
  by Abdullah Mosabbir, Quincy J. Almeida and Heidi Ahonen
  Healthcare 2020, 8(2), 113; https://doi.org/10.3390/healthcare8020113

JCM:

• “Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US”
  by Donald J. Alcendor
  J. Clin. Med. 2020, 9(8), 2442; https://doi.org/10.3390/jcm9082442

• “Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence”
  by Celestino Sardu, Jessica Gambardella, Marco Bruno Morelli, Xujun Wang, Raffaele Marfella and Gaetano Santulli
  J. Clin. Med. 2020, 9(5), 1417; https://doi.org/10.3390/jcm9051417

• “Estimation of the Transmission Risk of the 2019-nCoy and Its Implication for Public Health Interventions”
  by Biao Tang, Xia Wang, Qian Li, Nicola Luigi Bragazzi, Sanyi Tang, Yanni Xiao and Jianhong Wu
  J. Clin. Med. 2020, 9(2), 462; https://doi.org/10.3390/jcm9020462

JPM:

• “Molecular and Cellular Mechanisms Affected in ALS”
  by Laura Le Gall, Ekene Anakor, Owen Connolly, Udaya G. Vijayakumar, William J. Duddy and Stephanie Duguez
  J. Pers. Med. 2020, 10(3), 101; https://doi.org/10.3390/jpm10030101

• “Postulated Adjuvant Therapeutic Strategies for COVID-19”
  by Anderson O. Ferreira, Hudson C. Polonini and Eli C. F. Dijkers
  J. Pers. Med. 2020, 10(3), 80; https://doi.org/10.3390/jpm10030080

• “Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models”
  by Vincenzo Quagliariello, Margherita Passariello, Domenica Rea, Antonio Barbieri, Martina Iovine, Annamaria Bonelli, Antonietta Caronna, Gerardo Botti, Claudia De Lorenzo and Nicola Maurea
  J. Pers. Med. 2020, 10(4), 179; https://doi.org/10.3390/jpm10040179

Pharmaceutics:

• "Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics”
  by Carla B. Roces, Gustavo Lou, Nikita Jain, Suraj Abraham, Anitha Thomas, Gavin W. Halbert and Yvonne Perrie
  Pharmaceutics 2020, 12(11), 1095; https://doi.org/10.3390/pharmaceutics12111095

• “Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing”
  by Sawittree Sahakijpijarn, Chaeho Moon, John J. Koleng, Dale J. Christensen and Robert O. Williams III
  Pharmaceutics 2020, 12(11), 1002; https://doi.org/10.3390/pharmaceutics12111002

• “Skin Wound Healing Process and New Emerging Technologies for Skin Wound Care and Regeneration”
  by Erika Maria Tottoli, Rossella Dorati, Ida Genta, Enrica Chiesa, Silvia Pisani and Bice Conti
  Pharmaceutics 2020, 12(8), 735; https://doi.org/10.3390/pharmaceutics12080735

Pharmacy:

• “The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities, and Duties of the Pharmacist”
  by Nicola Luigi Bragazzi, Muhammad Mansour, Alessandro Bonsignore and Rosagemma Ciliberti
  Pharmacy 2020, 8(3), 140; https://doi.org/10.3390/pharmacy8030140

• “Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly”
  by David L. Bankes, Hubert Jin, Stephanie Finnel, Veronique Michaud, Calvin H. Knowlton, Jacques Turgeon and Alan Stein
  Pharmacy 2020, 8(2), 87; doi.org/10.3390/pharmacy8020087

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

MDPI will attend the 50th annual meeting of the Japanese Society of Neonatal Screening as an exhibitor. This meeting will be held in Niigata, Japan, from 25 to 26 August 2023.

The Japan Mass Screening Society started as a metabolic disorder screening study group established in 1973. At the national level, the world's top-level newborn screening is being carried out for more than 20 diseases. The society is made up of enthusiastic researchers and engineers from a wide range of fields, including obstetricians and gynecologists, pediatricians, basic medical researchers, and laboratory engineers. It has developed into an academic organization that has great significance in society.

The following MDPI journals will be represented:

• International Journal of Neonatal Screening (IJNS);
• Children;
• Cells;
• Healthcare.

If you are attending this conference, please feel free to start a conversation with us at our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://shinsen-mc.co.jp/jsns2023/.

With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.

The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.

Please feel free to browse and discover more about the new journals below.

Journal	Founding Editor-in-Chief	Journal topics (selected)
	Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue	growth and development; diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article
	Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue	DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article
	Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue	lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article
	Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue	multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article
	Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue	Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee ([email protected]) if you would like to create more new journals.

We are pleased to share that Healthcare (ISSN: 2227-9032) was awarded an Impact Factor of 2.8 in the 2022 Journal Citation Reports™ released by Clarivate in June 2023. Healthcare ranks in Q2 (43 among 87 titles) in the “Health Policy & Services” category.

Meanwhile, according to data released by Scopus (Elsevier), Healthcare received an updated CiteScore™ of 2.7, an increase of 35% compared with the 2021 metric.

Healthcare ranks 15 among 38 titles (Q2) in the “Leadership and Management” category.

For further statistics, please visit https://www.mdpi.com/journal/healthcare/stats. For more information about MDPI flagship journals' citation metrics, please see here.

The support and dedication of all journal editors, reviewers, authors, and readers are essential to our excellent performance. Thank you to everyone who has contributed to and supported our journal.

MDPI will attend the ESMO Congress 2023 as an exhibitor. This conference will be held in Madrid, Spain, from 20 to 24 October 2023.

The ESMO Congress is the most influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. They will disseminate the latest cutting-edge data, provide high-quality education and unparalleled networking opportunities for oncologists and other stakeholders from all around the world.

The following MDPI journals will be represented:

• Cancers;
• JCM;
• Cells;
• Diagnostics;
• Medical Sciences;
• Biomedicines;
• Geriatrics;
• Current Oncology;
• Hemato;
• Onco;
• CIMB;
• Healthcare.

If you are attending this conference, please feel free to start a conversation with us at our booth #724. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.esmo.org/meeting-calendar/esmo-congress-2023.

The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.

Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."

Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.

Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.

Source: 2022 Journal Impact Factors, Journal Citation Reports ^TM (Clarivate, 2023)

MDPI will attend the Annual Meeting of American Psychological Association 2023 (APA 2023) as an exhibitor. This meeting will be held in Washington DC, USA, from 3 to 5 August 2023.

The Annual Meeting of American Psychological Association is organized by the American Psychological Association annually. The American Psychological Association is the largest scientific and professional organization of psychologists in the United States, with over 146,000 members, including scientists, educators, clinicians, consultants, and students. APA 2023 will provide in-person engagement with psychology professionals (practitioners, researchers, scientists, academicians, students, and others) who seek solutions to the work challenges that they face within the field.

The following MDPI journals will be represented:

• Behavioral Sciences;
• J. Intell.;
• EJIHPE;
• Healthcare;
• JCM;
• Social Sciences;
• Psychoactives;
• Psych;
• Children;
• Psychiatry International.

If you are attending this conference, please feel free to start a conversation with us at our booth #244. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://convention.apa.org/.

Conference: WASOG 2023

Organization: The World Association of Sarcoidosis and Other Granulomatous Disorders

Date: 19–21 June 2023

Place: Aula Medica, Karolinska Institutet, Stockholm, Sweden

Booth: #7

MDPI will be attending the WASOG 2023 conference, which will be held from 19 to 21 June 2023 at Aula Medica, Karolinska Institutet, Stockholm, Sweden.

WASOG 2023 will offer a creative meeting ground for investigating how novel experimental, theoretical and computational approaches in Sarcoidosis and Interstitial Lung Diseases (ILDs) can improve our understanding of their underlying disease mechanisms. It aims to build an even stronger scientific bridge between different sectors, ultimately closing the knowledge gap and accelerating the development and spread of precision medicine in ILDs.

The following MDPI journals will be represented:

• Biomedicines;
• Clinics and Practice;
• Diagnostics;
• Diseases;
• Genes;
• Healthcare;
• Hematology Reports;
• IJTM;
• JCM;
• Medicines;
• Reports.

Please reach out ([email protected]) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

Conference: ATS (American Thoracic Society) Conference 2023
Date: 21–23 May 2023
Location: Washington DC, USA

MDPI will be attending ATS 2023 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference has been organized by the American Thoracic Society, and it will showcase the latest advances and discoveries in respiratory science, patient care and global respiratory health. At the conference, specialists will share and discuss the latest research and its applications to clinical, basic, and translational science in pulmonary, critical care, and sleep medicine.

The following MDPI journals will be represented:

• JCM;
• Medicina;
• Clinics and Practice;
• JPM;
• Cancers;
• Medicines;
• Healthcare;
• Metabolites;
• Children;
• Brain Sciences.

If you are planning to attend this conference, please do not hesitate to talk with us online. Our delegates look forward to meeting you in person at booth #2606, and answering any questions that you may have. For more information about the conference, please visit the following website: https://conference.thoracic.org/.

On 7 April 2023—World Health Day, the World Health Organization (WHO) will observe its 75th anniversary. In 1948, countries of the world came together and founded the WHO to promote health, keep the world safe, and serve the vulnerable, so that everyone, everywhere, can attain the highest level of health and well-being. The WHO’s 75th anniversary is an opportunity to look back at public health successes that have improved quality of life over the last seven decades. It is also an opportunity to motivate action to tackle the health challenges of today and tomorrow. In order to encourage everyone to understand health and pay attention to health, we have also curated a list of publications on topics related to universal health coverage, healthy diet, and mental health. We also want to remind everyone that all research published in MDPI journals is available in an open access format, allowing practitioners, policy makers, and people around the world to access the latest scientific knowledge to build upon and share. Although we still have a long way to go to achieve universal health, this day also provides an opportunity to celebrate the progress made and inspire further action toward a more just and equitable world. Join us on a journey at MDPI to achieve Health for All.

• The Antioxidant Potential of the Mediterranean Diet as a Predictor of Weight Loss after a Very Low-Calorie Ketogenic Diet (VLCKD) in Women with Overweight and Obesity

  Antioxidants 2023, 12(1), 18; https://doi.org/10.3390/antiox12010018

• Effectiveness of Non-Contact Dietary Coaching in Adults with Diabetes or Prediabetes Using a Continuous Glucose Monitoring Device: A Randomized Controlled Trial

  Healthcare 2023, 11(2), 252; https://doi.org/10.3390/healthcare11020252

• The Association between Advanced Liver Fibrosis and Mortality Is Modified by Dietary Quality among Korean Adults: Results from the Korea National Health and Nutrition Examination Survey with Mortality Data

  Nutrients 2023, 15(6), 1501; https://doi.org/10.3390/nu15061501

• Physical Exercise and Diet: Regulation of Gut Microbiota to Prevent and Treat Metabolic Disorders to Maintain Health

  Nutrients 2023, 15(6), 1539; https://doi.org/10.3390/nu15061539

• Modelling and Prediction of the Spread of COVID-19 in Cameroon and Assessing the Governmental Measures (March–September 2020)

  COVID 2021, 1(3), 622-644; https://doi.org/10.3390/covid1030052

• SARS-CoV-2 Infection in Health Care Workers of Trieste (North-Eastern Italy), 1 October 2020–7 February 2022: Occupational Risk and the Impact of the Omicron Variant

  Viruses 2022, 14(8), 1663; https://doi.org/10.3390/v14081663

• Vaccination Coverage during Childhood and Adolescence among Undergraduate Health Science Students in Greece

  Children 2022, 9(10), 1553; https://doi.org/10.3390/children9101553

• Determinants of Equity in Coverage of Measles-Containing Vaccines in Wales, UK, during the Elimination Era

  Vaccines 2023, 11(3), 680; https://doi.org/10.3390/vaccines11030680

• Sex Differences in Substance Use, Prevalence, Pharmacological Therapy, and Mental Health in Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)

  Brain Sci. 2022, 12(5), 590; https://doi.org/10.3390/brainsci12050590

• Impact on Students of the Act–Belong–Commit Mentally Healthy Schools Framework

  Children 2023, 10(3), 548; https://doi.org/10.3390/children10030548

• Psychological Health and Drugs: Data-Driven Discovery of Causes, Treatments, Effects, and Abuses

  Toxics 2023, 11(3), 287; https://doi.org/10.3390/toxics11030287

• Characterizing Touch Discrimination Impairment from Pooled Stroke Samples Using the Tactile Discrimination Test: Updated Criteria for Interpretation and Brief Test Version for Use in Clinical Practice Settings

  Brain Sci. 2023, 13(4), 533; https://doi.org/10.3390/brainsci13040533

Conference: 29th Congress of the European Association for Cancer Research
Date: 12–15 June 2023
Place: Torino, Italy

MDPI will be attending the 29th Congress of the European Association for Cancer Research, held in Torino, Italy, from 12 to 15 June 2023. This conference aims to achieve an in-depth exchange of the latest research results in the field of basic research, clinical application, cutting-edge technology, and industrial development in the field of cancer research over the year. During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest ideas with us.

The following MDPI journals will be represented:

• Cells;
• Cancers;
• Children;
• CIMB;
• Current Oncology;
• Diagnostics;
• Geriatrics;
• Healthcare;
• JCM;
• Medical Sciences.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://www.eacr2023.org/.

Healthcare (ISSN 2227-9032) is an international, peer-reviewed, Open Access journal (free for readers), which publishes original theoretical and empirical work in the interdisciplinary area of all aspects of medicine and healthcare research. 

Healthcare is recruiting new Section Editors-in-Chief with expertise in research and findings concerning the following six Sections:

• Healthcare Quality and Patient Safety;
• Chronic Care;
• Health Assessments;
• Medication Management;
• Pain Management;
• Medics. 

As a Section Editor-in-Chief, you have the following responsibilities:

• Acting as an ambassador for the journal, MDPI, and Open Access publishing;
• Scientific decisions about the scope of the Section;
• Inviting distinguished scientists to join the Editorial Board;
• Suggesting topics for Special Issues;
• Providing support and guidance to Editorial Board Members and Editorial Staff where required;
• Maintaining oversight of the editorial process for individual manuscripts in their section (mainly by making the final decision regarding whether or not a paper can be published after peer review and revisions);
• Understanding, leading in, and upholding MDPI’s peer review guidelines and ethics guidelines. 

If you are an active researcher in one of the aforementioned fields and are passionate about participating in the cutting-edge research of the corresponding field, please do not hesitate to contact us ([email protected]). 

Healthcare Editorial Office

As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.

In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.

If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to [email protected].

MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page. 

We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.

On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.

The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.

As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.

MDPI's Preprints Platform – Preprints.org

To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.

During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.

We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.

For more information, please visit Preprints.org.

We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.

This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.

The mentee’s responsibilities include:

• Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
• Writing a brief promotion plan for the Special Issue;
• Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
• Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

• Conducting a final check before the Special Issue is published online;
• Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
• Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
• Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
• Making and submitting decisions regarding submissions with the assistance of mentees.

Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.

If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.

In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.

MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.

This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.

Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.

Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.

Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.

As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.

A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.

MDPI is proud to be the leading agent of the transition to open access.

"Thanks a Million" to all the contributors!

We are pleased to announce the launch of a new initiative—the Special Issue Mentor Program. 

This program will enable early career researchers (must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and cultivate their ability to edit scientific research. 

The mentee’s responsibilities include:

• Proposing a Special Issue title and assisting mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Special Issue;
• Writing a brief promotion plan for the Special Issue;
• Preparing a list of scholars that may be interested in the issue and personally e-mailing the invitations on behalf of Guest Editors;
• Writing an editorial for the online Special Issue together with the mentor. 

The mentor’s responsibilities include:

• Conducting a final check before the Special Issue is published online;
• Performing editorial control of the Special Issue and quality control of the publications in a timely manner;
• Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
• Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
• Making and submitting decisions for the submissions with the assistance of mentees. 

Certificates and awards:

After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and mentees. 

If you are interested in this opportunity, please send your Special Issue proposal to the Healthcare Editorial Office ([email protected]), and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail.

In addition to the new Special Issue Mentor Program, Healthcare (ISSN: 2227-9032) will continue to welcome all Special Issue proposals focusing on hot research topics.

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.

The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).

The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.

Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.

Scientists at Stanford have recently published an update of the list of the top 2% most widely cited scientists—the World’s Top 2% Scientists. 

The time node of the statistical data of this list is from 1960 to 2022, and it is divided into two lists: "Lifetime Scientific Influence Ranking" and "2022 Annual Scientific Influence Ranking". The "Lifetime Scientific Influence Ranking" counts the comprehensive influence performance of scientists during their careers, and the "2022 Annual Influence Ranking" focuses on highlighting the academic influence of scientists in the previous year. This ranking, considered the most prestigious worldwide, is based on the bibliometric information contained in the Scopus database and includes more than 200,000 researchers from the more than 10 million scientists considered to be active worldwide, with 22 scientific fields and 176 subfields taken into account. 

We are pleased to share that 53 Editorial Board Members from MDPI’s journal Healthcare (ISSN: 2227-9032) were featured in Stanford University World’s Top 2% Scientists list in 2022.

The latest Stanford rankings reflect the significant influence and research excellence of the scientists, who are committed to furthering their knowledge for the benefit of the world. 

We would like to congratulate our Editorial Board Members on their excellent achievement and thank them for their immense contribution to the scientific progression and development of Healthcare.

MDPI will be attending the 27th Congress of the Chinese Pediatric Society, held in Changsha, China, from 15–18 December 2022.

The following MDPI journals will be represented:

• Children (leading journal);
• JPM;
• Medicina;
• Audiology Research;
• JCM;
• Healthcare;
• Diagnostics;
• Metabolites;
• Cancers;
• Nutrients. 

If you plan on attending this conference, feel free to stop by our booth: #B67. Our delegates look forward to meeting you in person to answer any questions that you may have. 

For more information about the conference, please see the following link: https://nccps2022.tiemeeting.com/CN.

MDPI will be attending the 15th European Public Health Conference 2022, held in Berlin, Germany, from 9 to 12 November 2022. The theme of Berlin 2022 is “Strengthening Health Systems: Improving Population Health and Being Prepared for the Unexpected”. This conference will aim to explore ways in which the public health community can rally around the principle of bringing about better population health. Meanwhile, the conference committee wants the discussions at the 15th EPH Conference to contribute to resilient health systems, universal health coverage (UHC), a well-trained and highly qualified clinical and public health workforce, and governance structures that take a stand and shape health systems globally.

During this conference, MDPI (at booth #13) will welcome researchers from different backgrounds to visit and share their latest ideas with us.

The following MDPI journals will be represented:

• IJERPH;
• Medicina;
• JCM;
• EJIHPE;
• Epidemiologia;
• Behavioral Sciences;
• Healthcare;
• Women;
• MPs;
• Nursing Report;
• COVID;
• Diseases;
• Data;
• Adolescents.

If you plan on attending this conference, feel free to stop by our booth at #13. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please see the following link: https://ephconference.eu/index.php.

We are honored to announce that Prof. Dr. Christian Napoli has been appointed Section Editor-in-Chief of the Section “Coronaviruses (CoV) and COVID-19 Pandemic” in Healthcare (ISSN: 2227-9032). 

The following is a short Q&A with Prof. Dr. Christian Napoli, who shared his vision for the journal with us, as well as his views of the research area and open access publishing: 

1. What appealed to you about the journal that made you want to take the role as its Editor-in-Chief?

My interest in Healthcare was, first of all, due to the wide range of leading topics managed. Moreover, the journal is characterized by high visibility, very rapid and rigorous peer reviewing, and is independent from scientific medical societies.

Over the past years, I served both as a referee and an Academic Editor and I experienced constructive cooperation with the Editorial Office, supporting the Editorial Board and greatly contributing to the serious and transparent approach in the peer-review process.

For all these reasons, and considering my scientific background, I decided to accept the role of the Section Editor-in-Chief with regard to the Section “Coronaviruses (CoV) and COVID-19 Pandemic”. 

2. What is your vision for the journal?

The scientific literature has impressively grown with regard to the study of the COVID-19 pandemic, but much is still to be known. Therefore, by attracting high-quality manuscripts for this Section, it is my belief that the journal will be able to provide further evidence useful for understanding missing information in the field of COVID-19 epidemiology, diagnosis, treatment and prevention. 

3. What does the future of this field of research look like?

It is well known that, despite the reduction of severe forms, the pandemic is still ongoing. At the same time, the scientific research on this topic has been stimulated and improved. Therefore, in the future we will see the results of a very large number of studies providing more precise evidence. In a world where the pandemic has changed the way of thinking about healthcare, a wide range of studies related to this issue will have the possibility to be published. Thus, I expect a large submission of manuscripts in the near future. 

4. What do you think of the development of open access in the publishing field?

In my opinion, to guarantee open access for published papers is primary and fundamental for the dissemination of scientific evidence. In fact, it ensures that published articles are easily accessible to anyone interested in them, independent of the scientific sectors. Therefore, it is my opinion that all scientific journals should use an open access approach, as it is the only way to enhance both the exchange of knowledge between scientists and the user-friendliness of the provided scientific evidence. 

We wish Prof. Dr. Christian Napoli every success in his new position, and we look forward to his contributions to the journal. 

Healthcare Editorial Office

Conference: The 20th International Congress for Tropical Medicine and Malaria (ICTMM2020)
Date: 24–28 October 2022
Place: Bangkok, Thailand
Booth: B02

MDPI will be attending the 20th International Congress for Tropical Medicine and Malaria (ICTMM2020) from 24 to 28 October 2022 in Bangkok, Thailand.

The ICTMM is one of the largest tropical-medicine conferences in the world, gathering more than 2,000 scientists, researchers, and experts every four years. It offers an excellent opportunity for delegates to exchange knowledge on tropical medicine with people from all over the world who share the same research interests. The congress will cover topics and updates on tropical medicine, malaria, infectious diseases, neglected diseases, drug resistance, parasitology, zoonoses, and travel medicine, to name just a few.

The following MDPI journals will be represented:

• TropicalMed;
• Diagnostics;
• Diseases;
• Future Pharmacology;
• Healthcare;
• IJERPH;
• Parasitologia;
• Pathogens;
• Pharmaceutics.

Please do not hesitate to reach out ([email protected]) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

For more information about the conference, please visit the following website: https://ictmm2020.org/.

Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.

To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.

We invite you to view the event recording:

During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:

• Peer Review Week 2022
• Research Integrity
• What We’ve Learned About Peer Review Reports
• 4 Steps to the Perfect Peer Review Report
• How to Write the Perfect Peer Review Report: An Interview
• Inviting Great Peer Reviewers

In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.

You can find the Podcast here.

We hope you enjoy the contents!

MDPI will be attending the 34th Annual Conference of the International Society for Environmental Epidemiology (ISEE 2022), held in Athens, Greece, from 18 to 21 September 2022. The main theme of the 2022 conference is “Strengthening the global role of environmental epidemiology”, stressing the need to study and understand local conditions in order to synthesize knowledge and make a difference for our planet. In the 2022 conference we will continue advancing our society’s aims in promoting epidemiological studies that link environmental exposures to human health.

During this conference, MDPI (at booth #22) will welcome researchers from different backgrounds to visit and share their latest inspirations with us.

The following MDPI journals will be represented:

• IJERPH (leading journal);
• Sustainability;
• Healthcare;
• Children;
• Cancers;
• Climate;
• Environments;
• Earth;
• Societies;
• Epidemiologia.

If you plan on attending this conference, feel free to stop by our booth: #22. Our delegates look forward to meeting you in person to answer any questions that you may have.

For more information about the conference, please see the following link: https://isee2022.org/.

1. “A Deep Learning Approach for Brain Tumor Classification and Segmentation Using a Multiscale Convolutional Neural Network”
by Francisco Javier Díaz-Pernas, Mario Martínez-Zarzuela, Míriam Antón-Rodríguez and David González-Ortega
Healthcare 2021, 9(2), 153; https://doi.org/10.3390/healthcare9020153
Available online: https://www.mdpi.com/2227-9032/9/2/153

2. “Assessing the Psychological Impact of COVID-19 among College Students: An Evidence of 15 Countries”
by Kavita Batra, Manoj Sharma, Ravi Batra, Tejinder Pal Singh and Nena Schvaneveldt
Healthcare 2021, 9(2), 222; https://doi.org/10.3390/healthcare9020222
Available online: https://www.mdpi.com/2227-9032/9/2/222

3. “A Fusion-Based Machine Learning Approach for the Prediction of the Onset of Diabetes”
by Muhammad Waqas Nadeem, Hock Guan Goh, Vasaki Ponnusamy, Ivan Andonovic, Muhammad Adnan Khan and Muzammil Hussain
Healthcare 2021, 9(10), 1393; https://doi.org/10.3390/healthcare9101393
Available online: https://www.mdpi.com/2227-9032/9/10/1393

4. “Nurses’ Workplace Conditions Impacting Their Mental Health during COVID-19: A Cross-Sectional Survey Study”
by Farinaz Havaei, Andy Ma, Sabina Staempfli and Maura MacPhee
Healthcare 2021, 9(1), 84; https://doi.org/10.3390/healthcare9010084
Available online: https://www.mdpi.com/2227-9032/9/1/84

5. “Dental Education Challenges during the COVID-19 Pandemic Period in Italy: Undergraduate Student Feedback, Future Perspectives, and the Needs of Teaching Strategies for Professional Development”
by Giuseppe Varvara, Sara Bernardi, Serena Bianchi, Bruna Sinjari and Maurizio Piattelli
Healthcare 2021, 9(4), 454; https://doi.org/10.3390/healthcare9040454
Available online: https://www.mdpi.com/2227-9032/9/4/454

6. “Religious Coping, Depression and Anxiety among Healthcare Workers during the COVID-19 Pandemic: A Malaysian Perspective”
by Soon Ken Chow, Benedict Francis, Yit Han Ng, Najmi Naim, Hooi Chin Beh, Mohammad Aizuddin Azizah Ariffin, Mohd Hafyzuddin Md Yusuf, Jia Wen Lee and Ahmad Hatim Sulaiman
Healthcare 2021, 9(1), 79; https://doi.org/10.3390/healthcare9010079
Available online: https://www.mdpi.com/2227-9032/9/1/79

7. “Vaccine Enthusiasm and Hesitancy in Cancer Patients and the Impact of a Webinar”
by Amar H. Kelkar, Jodian A. Blake, Kartikeya Cherabuddi, Hailee Cornett, Bobbie L. McKee and Christopher R. Cogle
Healthcare 2021, 9(3), 351; https://doi.org/10.3390/healthcare9030351
Available online: https://www.mdpi.com/2227-9032/9/3/351

8. “The Effect of Menopause Hypoestrogenism on Osteogenic Differentiation of Periodontal Ligament Cells (PDLC) and Stem Cells (PDLCs): A Systematic Review”
by Edoardo Di Naro, Matteo Loverro, Ilaria Converti, Maria Teresa Loverro, Elisabetta Ferrara and Biagio Rapone
Healthcare 2021, 9(5), 572; https://doi.org/10.3390/healthcare9050572
Available online: https://www.mdpi.com/2227-9032/9/5/572

9. “Burnout Prevalence and Its Associated Factors among Malaysian Healthcare Workers during COVID-19 Pandemic: An Embedded Mixed-Method Study”
by Nurhanis Syazni Roslan, Muhamad Saiful Bahri Yusoff, Ab Razak Asrenee and Karen Morgan
Healthcare 2021, 9(1), 90; https://doi.org/10.3390/healthcare9010090
Available online: https://www.mdpi.com/2227-9032/9/1/90

10. “Long-COVID Syndrome? A Study on the Persistence of Neurological, Psychological and Physiological Symptoms”
by Graziella Orrù, Davide Bertelloni, Francesca Diolaiuti, Federico Mucci, Mariagrazia Di Giuseppe, Angelo Gemignani, Rebecca Ciacchini and Ciro Conversano
Healthcare 2021, 9(5), 575; https://doi.org/10.3390/healthcare9050575
Available online: https://www.mdpi.com/2227-9032/9/5/575

11. “A Novel Method for a COVID-19 Classification of Countries Based on an Intelligent Fuzzy Fractal Approach”
by Oscar Castillo and Patricia Melin
Healthcare 2021, 9(2), 196; https://doi.org/10.3390/healthcare9020196
Available online: https://www.mdpi.com/2227-9032/9/2/196

12. “Obesity in Saudi Arabia in 2020: Prevalence, Distribution, and Its Current Association with Various Health Conditions”
by Nora A. Althumiri, Mada H. Basyouni, Norah AlMousa, Mohammed F. AlJuwaysim, Rasha A. Almubark, Nasser F. BinDhim, Zaied Alkhamaali and Saleh A. Alqahtani
Healthcare 2021, 9(3), 311; https://doi.org/10.3390/healthcare9030311
Available online: https://www.mdpi.com/2227-9032/9/3/311

13. “Ixekizumab May Improve Renal Function in Psoriasis”
by Giuseppe Fabrizio Amoruso, Steven Paul Nisticò, Luigi Iannone, Emilio Russo, Giuseppe Rago, Cataldo Patruno and Luigi Bennardo
Healthcare 2021, 9(5), 543; https://doi.org/10.3390/healthcare9050543
Available online: https://www.mdpi.com/2227-9032/9/5/543

14. “Traumatic Events and Eagle Syndrome: Is There Any Correlation? A Systematic Review”
by Sabina Saccomanno, Vincenzo Quinzi, Nicola D’Andrea, Arianna Albani, Licia Coceani Paskay and Giuseppe Marzo
Healthcare 2021, 9(7), 825; https://doi.org/10.3390/healthcare9070825
Available online: https://www.mdpi.com/2227-9032/9/7/825

15. “The Association between Future Anxiety, Health Literacy and the Perception of the COVID-19 Pandemic: A Cross-Sectional Study”
by Mariusz Duplaga and Marcin Grysztar
Healthcare 2021, 9(1), 43; https://doi.org/10.3390/healthcare9010043
Available online: https://www.mdpi.com/2227-9032/9/1/43

16. “The Modern and Digital Transformation of Oral Health Care: A Mini Review”
by Muhammad Syafiq Alauddin, Ahmad Syukran Baharuddin and Mohd Ifwat Mohd Ghazali
Healthcare 2021, 9(2), 118; https://doi.org/10.3390/healthcare9020118
Available online: https://www.mdpi.com/2227-9032/9/2/118

17. “Catering Work Profession and Medico-Oral Health: A Study on 603 Subjects”
by Sabina Saccomanno, Stefano Mummolo, Silvia Giancaspro, Rebecca Jewel Manenti, Rodolfo Francesco Mastrapasqua, Giuseppe Marzo and Vincenzo Quinzi
Healthcare 2021, 9(5), 582; https://doi.org/10.3390/healthcare9050582
Available online: https://www.mdpi.com/2227-9032/9/5/582

18. “What Will Be the Impact of the COVID-19 Quarantine on Psychological Distress? Considerations Based on a Systematic Review of Pandemic Outbreaks”
by Marco Cavicchioli, Roberta Ferrucci, Matteo Guidetti, Maria Paola Canevini, Gabriella Pravettoni and Federica Galli
Healthcare 2021, 9(1), 101; https://doi.org/10.3390/healthcare9010101
Available online: https://www.mdpi.com/2227-9032/9/1/101

19. “Combining Public Opinion Dissemination with Polarization Process Considering Individual Heterogeneity”
by Tinggui Chen, Jingtao Rong, Jianjun Yang, Guodong Cong and Gongfa Li
Healthcare 2021, 9(2), 176; https://doi.org/10.3390/healthcare9020176
Available online: https://www.mdpi.com/2227-9032/9/2/176

20. “Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review”
by Giuseppe Davide Albano, Francesco Amico, Giuseppe Cocimano, Aldo Liberto, Francesca Maglietta, Massimiliano Esposito, Giuseppe Li Rosi, Nunzio Di Nunno, Monica Salerno and Angelo Montana
Healthcare 2021, 9(1), 97; https://doi.org/10.3390/healthcare9010097
Available online: https://www.mdpi.com/2227-9032/9/1/97

We are honored to announce that Prof. Dr. Robbert Gobbens has been appointed Section Editor-in-Chief of the Section “Community Care” in Healthcare (ISSN: 2227-9032).

The following is a short Q&A with Prof. Dr. Robbert Gobbens, who shared his vision for the journal with us, as well as his views of the research area and open access publishing:

The journal Healthcare was established in 2013. From that point on, Healthcare has continued to evolve. Healthcare is characterized by high visibility because it is indexed within important databases such as PubMed, Scopus and SSCI (Web of Science). In addition, Healthcare has a 5-year Impact Factor of 3.460. Over the past year, I have been active as an academic editor. During that time, I have found that the peer review process is very carefully conducted. Additionally, the cooperation with the staff of the Healthcare Editorial Office was pleasant. For all these reasons, I decided to take on the role of Section Editor-in-Chief with regard to the Section “Community Care”. Given my background as a district nurse and my focus on research on community-dwelling older people, this Section fits very well with me. 

The journal provides rapid publication; after approximately 20 days after submission, a first decision is provided to the authors. This is important and I am happy to contribute to this. Healthcare is now ranked 50/109 (Q2) in the category “Health Care Sciences & Services”, and 35/88 (Q2) in the “Health Policy & Services” category. By selecting high quality manuscripts for the Section “Community Care”, I also want to make sure that these rankings are higher next year. Through Special Issues, we will highlight particular topics for “Community Care”. 

Community Care is focused on the support of people with disabilities living and participating in society, from the society itself. In the Section “Community Care”, a wide diversity of studies related to people with disabilities can be included, such as studies on housing and residential environment, education, work, traffic and transport, friends and relatives, recreation and leisure, health and healthcare. It presents a challenge to reflect on that wide range of topics. When it comes to community care, older people (e.g., people with dementia) are rather quickly thought of, and this is an important target group for the Section, but studies of younger people with disabilities are also included. Community care is common in many countries spread over the world, so I expect a large submission of manuscripts in the near future. 

In my opinion, the development of open access in the publishing field is positive. In fact, it ensures that published articles are easily accessible to anyone interested in them, whether they are scientists, people from practice (e.g., healthcare professionals), or lecturers. I am convinced that, sooner or later, all scientific journals will transfer to open access.

We wish Prof. Dr. Robbert Gobbens every success in his new position, and we look forward to his contributions to the journal.

Healthcare Editorial Office

Conference: 15th China Nutrition Science Congress
Date: 29–31 July 2022
Place: Wuhan, China
Booth: #3

Nutrients (ISSN: 2072-6643) will be attending the 15th China Nutrition Science Congress 2022 as an exhibitor from 29 to 31 July in Wuhan, China.

The 15th China Nutrition Science Congress is a key academic activity of The Chinese Nutrition Society, which is a scientific grand meeting in the nutrition field, and an important platform to display the latest research results on nutrition in China, sharing the latest research progress in the field of nutrition.

The theme of the conference is “Food Nutrition and Health”. The conference will host many well-known experts and outstanding scholars in the field of nutrition and health to discuss basic theoretical research and the application of food nutrition and health, the latest breakthroughs in the field of nutrition, exchange new academic ideas and new methods, and forecast the future development trends of nutrition.

The following MDPI journals will be represented:

• Nutrients;
• Children;
• CIMB;
• Fermentation;
• Foods;
• Healthcare;
• Nutraceuticals;
• Obesities;
• Women.

Please do not hesitate to contact us if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

For more information about the conference, please visit the following link: https://cnsc2021.sciconf.cn/cn/web/index/11176.

The 2021 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

For more information on Impact Factors and what it means to index academic journals, please visit our related blog posts.

* Journals given their first Impact Factor in 2022

Source: 2021 Journal Impact Factors, Journal Citation Reports ^TM (Clarivate, 2022)

MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2021 in the “Medicine & Pharmacology” category. The winners were selected by the journals’ editors.

We warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Biomedicines:

• Jasper Fuk-Woo Chan, Queen Mary Hospital, Hong Kong
• Mateusz Maciejczyk, Medical University of Bialystok, Poland

Current Oncology:

• Matteo Lambertini, University of Genova, Italy

Dentistry Journal:

• Helen Rogers, Newcastle University, UK

Healthcare:

• Amir Karami, University of South Carolina, USA

Journal of Clinical Medicine:

• Andrea Palermo, Campus Bio-Medico University, Italy

Journal of Personalized Medicine:

• Simone Di Franco, University of Palermo, Italy
• Catriona Hippman, University of Calgary, Canada

Medicina:

• Veeru Kasivisvanathan, University College London, UK
• Andrea Cortegiani, University of Palermo, Italy; University Hospital Policlinico Paolo Giaccone, Italy

Pharmaceutics:

• Qi Zhou, Purdue University, USA

We are proud to recognize the winners of MDPI’s 2021 Travel Awards in the “Medicine & Pharmacology” category for their outstanding presentations and to present them with the prize.

MDPI journals regularly offer travel awards to encourage talented junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the Travel Awards winners for the year 2021 and wish them the greatest success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Biomedicines:

• Soheil Saeedi, University of Zurich, Switzerland

Dentistry Journal:

• Shawn Alexander Hallett, University of Michigan, USA

Medicines:

• Claire Albert, Yale University, USA

Pharmaceuticals:

• Raquel Filipa da Costa Viveiros, NOVA University of Lisbon, Portugal
• Patrick Jim Küppers, University Hospital Bonn, Germany

In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers, and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize winners for the year 2021 in the “Medicine & Pharmacology” category for their outstanding contributions among extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievement. MDPI will continue to provide support and recognition to the academic community.

Cancers:

• Antonio G. Solimando, University of Bari Aldo Moro, Italy
• Chenghui Li, University of Arkansas for Medical Sciences, USA
• Joaquim Carreras, Tokai University, Japan
• Pierfrancesco Franco, University of Turin School of Medicine, Italy
• Laurentiu Pop, University of Texas Southwestern Medical Center, USA

Current Oncology:

• Margaret Fitch, University of Toronto, Canada
• Caroline Mariano, BC Cancer Agency, Canada; University of British Columbia, Canada

Healthcare:

• Naser Alsharairi, Griffith University, Australia
• Peter W. Choate, Mount Royal University, Canada
• Qin Xiang Ng, National University of Singapore, Singapore

Journal of Clinical Medicine:

• Giulio Francesco, Sapienza University of Rome, Italy
• Sebastian Schnaubelt, Medical University of Vienna, Austria
• Olga Kislitsina, Northwestern University, Northwestern Memorial Hospital, USA

Journal of Personalized Medicine:

• Onofrio Laselva, University of Foggia, Italy
• Ping-Hsun Wu, Kaohsiung Medical University, Taiwan
• Vladimir Vladimirov, Virginia Commonwealth University, USA
• Mauro Giuffrè, University of Trieste, Italy

Medical Sciences:

• Erika Palmieri, National Cancer Institute at Frederick, USA

Tomography:

• Anjul Khadria, California Institute of Technology, Pasadena, USA

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as the scientific merit, overall impact, and the quality of presentation of the papers published in the journal last year.

We are honored to present the winners in the “Medicine & Pharmacology” category, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications.

MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

• “Antimicrobial and Synergistic Effects of Commercial Piperine and Piperlongumine in Combination with Conventional Antimicrobials”

by Eunice Ego Mgbeahuruike, Milla Stålnacke, Heikki Vuorela and Yvonne Holm

Antibiotics 2019, 8(2), 55; doi:10.3390/antibiotics8020055

• “Antibiotic Discovery: Where Have We Come from, Where Do We Go?”

by Bernardo Ribeiro da Cunha, Luís P. Fonseca and Cecília R. C. Calado

Antibiotics 2019, 8(2), 45; doi:10.3390/antibiotics8020045

Dentistry Journal:

• “Regeneration of the Periodontal Apparatus in Aggressive Periodontitis Patients”

by Zvi Artzi, Shiran Sudri, Ori Platner and Avital Kozlovsky

Dent. J. 2019, 7(1), 29; doi:10.3390/dj7010029

• “Treatment of Peri-Implant Mucositis with Repeated Application of Chlorhexidine Chips or Gel during Supportive Therapy—A Randomized Clinical Trial”

by Philipp Sahrmann, Cyrill Bettschart, Daniel B. Wiedemeier, Ahmed Al-Majid, Thomas Attin and Patrick R. Schmidlin

Dent. J. 2019, 7(4), 115; doi:10.3390/dj7040115

Healthcare:

• “Two-Year Use of Care Robot Zora in Dutch Nursing Homes: An Evaluation Study”

by Chantal Huisman and Helianthe Kort

Healthcare 2019, 7(1), 31; doi:10.3390/healthcare7010031

• “The Interlinked Rising Epidemic of Insufficient Sleep and Diabetes Mellitus”

by Vijay Kumar Chattu, Soosanna Kumary Chattu, Deepa Burman, David Warren Spence and Seithikurippu R. Pandi-Perumal

Healthcare 2019, 7(1), 37; doi:10.3390/healthcare7010037

Journal of Clinical Medicine:

• “Periodontitis: A Multifaceted Disease of Tooth-Supporting Tissues”

by Eija Könönen, Mervi Gursoy and Ulvi Kahraman Gursoy

Clin. Med. 2019, 8(8), 1135; doi:10.3390/jcm8081135

• “The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity”

by Yueyuan Zhou, Yusuke Yamamoto, Zhongdang Xiao and Takahiro Ochiya

Clin. Med. 2019, 8(7), 1025; doi:10.3390/jcm8071025

• “Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR”

by Tara K. Sigdel, Felipe Acosta Archila, Tudor Constantin, Sarah A. Prins, Juliane Liberto, Izabella Damm, Parhom Towfighi, Samantha Navarro, Eser Kirkizlar, Zachary P. Demko, Allison Ryan, Styrmir Sigurjonsson, Reuben D. Sarwal, Szu-Chuan Hseish, Chitranon Chan-On, Bernhard Zimmermann, Paul R. Billings, Solomon Moshkevich and Minnie M. Sarwal

Clin. Med. 2019, 8(1), 19; doi:10.3390/jcm8010019

Medicina:

• “Tumor Microenvironment”

by Borros Arneth

Medicina 2020, 56(1), 15; doi: 10.3390/medicina56010015

• “Comparative Epidemiology and Resistance Trends of Common Urinary Pathogens in a Tertiary-Care Hospital: A 10-Year Surveillance Study”

by Márió Gajdács, Marianna Ábrók, Andrea Lázár, and Katalin Burián

Medicina 2019, 55(7), 356; doi: 10.3390/medicina55070356

Pharmaceutics:

• “3D Printed Pellets (Miniprintlets): A Novel, Multi-Drug, Controlled Release Platform Technology”

by Atheer Awad, Fabrizio Fina, Sarah J. Trenfield, Pavanesh Patel, Alvaro Goyanes, Simon Gaisford and Abdul W. Basit.

Pharmaceutics 2019, 11(4), 148; doi:10.3390/pharmaceutics11040148

• “Mathematical Modeling of Release Kinetics from Supramolecular Drug Delivery Systems”

by Constantin Mircioiu, Victor Voicu, Valentina Anuta, Andra Tudose, Christian Celia, Donatella Paolino, Massimo Fresta, Roxana Sandulovici and Ion Mircioiu

Pharmaceutics 2019, 11(3), 140; doi:10.3390/pharmaceutics11030140

The 2021 citation metrics have been officially released in Scopus!

We are pleased to announce that 182 MDPI journals are included, of which:

● 21 journals received their first CiteScore.
● 85% of journals increased their CiteScore from 2020.
● 155 journals (85%) ranked above average, in at least one category.

The following 65 MDPI journals (36%) ranked among the top 25% of journals, in at least one category: